Hillstream BioPharma (NASDAQ:HILS) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Hillstream BioPharma

BRIEF

published on 09/30/2024 at 13:05, 2 months 21 days ago

Tharimmune and Intract Pharma to Merge and Form Transformative Oral Biologics Company

Merger Biotechnology Tharimmune Intract Pharma Oral Biologics
BRIEF

published on 09/30/2024 at 13:05, 2 months 21 days ago

Tharimmune et Intract Pharma fusionnent pour former une société innovante de produits biologiques oraux

Biotechnologie Fusionnement Tharimmune Intract Pharma Produits Biologiques Oraux
PRESS RELEASE

published on 09/30/2024 at 13:00, 2 months 21 days ago

Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Tharimmune, Inc. and Intract Pharma to merge, creating transformative oral biologics company. Merger expected to enhance pipeline growth, innovation, and patient outcomes in the biologics market

Merger Tharimmune Intract Pharma Oral Biologics Pipeline Growth
BRIEF

published on 09/16/2024 at 13:05, 3 months 5 days ago

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop Oral Infliximab

Autoimmune Diseases Tharimmune Intract Pharma Infliximab Oral Delivery
BRIEF

published on 09/16/2024 at 13:05, 3 months 5 days ago

Tharimmune acquiert une licence mondiale et s'associe à Intract Pharma pour développer l'infliximab oral

Maladies Auto-immunes Tharimmune Intract Pharma Infliximab Administration Orale
PRESS RELEASE

published on 09/16/2024 at 13:00, 3 months 5 days ago

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab
Tharimmune partners with Intract Pharma to license oral anti-TNF-α antibody for autoimmune diseases. The innovative delivery platform aims to enhance treatment effectiveness and patient compliance

Autoimmune Diseases Tharimmune Intract Pharma Oral Delivery Anti-TNF-α Antibody
PRESS RELEASE

published on 09/22/2023 at 14:30, 1 year 2 months ago

Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.

Accesswire

Published on 12/21/2024 at 01:30, 18 hours 8 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 8 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 33 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 38 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 20 hours 8 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 46 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 53 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 20 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 20 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE